Reveal LINQ vs cV4 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Reveal LINQ

by Medtronic

cV4 Diagnostic Ultrasound System

by Samsung Medison

AI Verdict

Tool A, the Medtronic Reveal LINQ, is an implantable cardiac monitor designed for long-term, continuous ECG recording and AI-powered arrhythmia detection. In contrast, Tool B, the Samsung Medison cV4, is an AI-enabled diagnostic ultrasound system primarily used for real-time imaging and automated assessments across various specialties, including cardiology, obstetrics, and radiology. While both leverage AI in cardiology, the Reveal LINQ focuses on electrical rhythm monitoring, whereas the cV4 provides anatomical and functional imaging, making them suitable for distinct diagnostic scenarios.

Choose Reveal LINQ if…

Choose Reveal LINQ if your patient requires long-term, continuous cardiac rhythm monitoring to detect infrequent or asymptomatic arrhythmias that may be missed by shorter-term methods. This tool is ideal for diagnosing conditions like cryptogenic stroke, unexplained syncope, or paroxysmal atrial fibrillation, offering up to three years of ECG data collection with AI-powered accuracy.

View Reveal LINQ →

Choose cV4 Diagnostic Ultrasound System if…

Choose the Samsung Medison cV4 if your clinical practice demands a versatile, high-performance diagnostic imaging solution with integrated AI for real-time assistance. This system is particularly well-suited for specialties like OB/GYN, where features such as HeartAssist™ and BiometryAssist™ can streamline fetal assessments, or for general radiology requiring advanced image quality and robust data security for diverse diagnostic needs.

View cV4 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Reveal LINQ	cV4 Diagnostic Ultrasound System
Deployment	The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.	On-premise
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Reveal LINQ

Tool A, the Reveal LINQ, is an implantable device designed for minimal invasiveness and continuous, long-term monitoring, which significantly enhances patient usability by being largely invisible and requiring less active patient management. Its wireless data transmission and clinician mobile app also streamline workflows for healthcare providers.

Clinical Value

Reveal LINQ

Tool A offers continuous ECG monitoring for up to three years with AI algorithms (AccuRhythmu2122) specifically designed to reduce false alerts, leading to more accurate detection and diagnosis of critical cardiac arrhythmias. This direct improvement in diagnostic accuracy and reduction in clinician burden provides a high clinical impact for often elusive conditions.

Pricing & Value

Tie

Both tools follow the standard medical device pricing model, requiring direct contact with the vendor for quotes, and neither provides public pricing details. Without specific cost or return-on-investment data, it is impossible to determine which offers superior pricing or value.

Enterprise Readiness

cV4 Diagnostic Ultrasound System

While both are FDA-cleared and HIPAA-compliant, Tool B explicitly details robust cybersecurity features such as SSD encryption (BitLocker), DICOM TLS for transmission, and audit trails, running on Windows 11 OS. These specific technical safeguards demonstrate a comprehensive approach to enterprise data security and integration.

Innovation

Reveal LINQ

Tool A stands out with its claim as the 'world's smallest insertable cardiac monitor' and its AccuRhythmu2122 AI algorithms specifically engineered to reduce false alerts for AF and pauses. This combination of miniaturization, long-term monitoring, and AI-driven diagnostic accuracy represents a significant innovation in cardiac rhythm management.

Support & Docs

Tie

Both Medtronic and Samsung Medison are large, established global medical device manufacturers with extensive resources. While specific details on support quality or documentation comprehensiveness are not provided in the structured facts or readily available for direct comparison, both companies are expected to offer robust support and documentation for their products.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Reveal LINQ	cV4 Diagnostic Ultrasound System
Name	Reveal LINQ	cV4 Diagnostic Ultrasound System
Company	Medtronic	Samsung Medison Co.
Description Summary	Tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias.	AI-enabled, fanless diagnostic ultrasound system offering advanced imaging, streamlined workflows, and robust data security for diverse clinical applications.
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, OB/GYN AI, Radiology & Imaging AI
Key AI Algorithms/Features	AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause).	HeartAssistu2122 for automated fetal heart assessment, NerveTracku2122 for real-time nerve detection, BiometryAssistu2122 for automated fetal measurements, LaborAssistu2122 for fetal angle of progression estimation.